Australia markets closed

Vanda Pharmaceuticals Inc (VM4.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
5.0000-0.1000 (-1.96%)
At close: 09:59PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-4,889
2,509
6,275
33,152
23,337
Depreciation & amortisation
4,564
3,010
2,733
2,841
2,864
Deferred income taxes
-3,546
-1,286
1,130
6,745
6,189
Stock-based compensation
13,273
14,040
16,279
15,374
13,360
Change in working capital
-15,809
-747
6,074
2,737
4,317
Accounts receivable
-12,195
-707
-1,089
-2,469
-3,767
Inventory
-816
-771
-4,479
-2,233
-2,876
Accounts payable
972
-10,984
11,793
3,040
3,759
Other working capital
-11,772
12,418
31,305
63,662
49,980
Other non-cash items
2,951
3,419
2,456
1,728
1,758
Net cash provided by operating activities
-11,433
12,801
31,984
64,214
51,775
Cash flows from investing activities
Investments in property, plant and equipment
-339
-383
-679
-552
-1,795
Acquisitions, net
-103,370
-100,665
0
0
-
Purchases of investments
-425,567
-512,606
-349,258
-420,461
-346,622
Sales/maturities of investments
311,708
601,598
399,862
344,317
306,918
Net cash used for investing activities
-217,568
-12,056
49,925
-76,696
-41,499
Cash flows from financing activities
Common stock issued
-
-
-
-
0
Net cash used provided by (used for) financing activities
-
0
734
3,550
5,634
Net change in cash
-229,013
792
82,908
-9,023
15,963
Cash at beginning of period
354,640
135,498
52,590
61,613
45,650
Cash at end of period
125,639
136,290
135,498
52,590
61,613
Free cash flow
Operating cash flow
-11,433
12,801
31,984
64,214
51,775
Capital expenditure
-339
-383
-679
-552
-1,795
Free cash flow
-11,772
12,418
31,305
63,662
49,980